We appreciate the commentary by Polyzos et al. ([@B1]), which brings to light current evidence on the association between *Helicobacter pylori (H. pylori)* infection and insulin resistance. As the authors note in their review of our article ([@B2]), six of eight studies identified significantly elevated levels of insulin resistance in those infected with *H. pylori* compared with uninfected control subjects, suggesting a possible mechanistic relationship between *H. pylori* and diabetes ([@B3]). However, all eight studies were cross-sectional in design and most had not adjusted for potential confounders, warranting the need for larger prospective studies with more rigorous methods. We conducted a prospective study to try and capture the possible temporal relationship between *H. pylori* infection and development of diabetes ([@B2]). Although we did not find an association between *H. pylori* infection and baseline levels of insulin resistance, we did identify a significant association between *H. pylori* and increased rate of diabetes over 10 years of follow-up ([@B2]).

The four potential mechanisms Polyzos et al. have set forth ([@B1]) are conceivable and could operate individually or collectively. We focused our efforts on the inflammatory pathway as a potential mechanism linking infection and diabetes, but our data did not substantiate the hypothesis, since interleukin-6 and C-reactive protein levels were not different between *H. pylori* infected and noninfected individuals at baseline. As Polyzos et al. mentioned, baseline levels of inflammatory markers may not have been as relevant as those measured after baseline prior to incident diabetes, which unfortunately were not available in our study. Polyzos et al. also pointed to the potential role of proatherogenic factors, such as homocysteine. The distribution of homocysteine and folate levels had been examined in our population, but they did not differ by *H. pylori* infection status.

It is possible that mechanisms that do not necessarily involve inflammation and proatherogenic factors are responsible for the association between *H. pylori* and diabetes. For example, another mechanism of interest is how the gut microbiota could affect insulin resistance and diabetes through altered energy harvesting and lipid metabolism ([@B4]). We expect that contemporaneous research on the influence of bacterial pathogens and endotoxins on inflammation, nutrient absorption, glucose, and lipid metabolism will help unravel the specific mechanisms at play in the interaction between *H. pylori* and diabetes. Longitudinal studies that investigate mediating physiological measures en route from infection to insulin resistance and diabetes would be particularly enlightening.
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